{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:55:11Z","timestamp":1788897311092,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To assess fractures in monoclonal gammopathy of undetermined significance (MGUS), the precursor of multiple myeloma, we followed 488 Olmsted County, MN, residents with MGUS in a retrospective cohort study. There was a 2.7-fold increase in the risk of axial fractures but no increase in limb fractures. The pathophysiologic basis for the increased axial fractures should be determined.<\/jats:p>\n               <jats:p>Introduction: Multiple myeloma is often preceded by monoclonal gammopathy of undetermined significance (MGUS). Fractures are common in myeloma as a result of lytic bone lesions, generalized bone loss, and elevated bone turnover from excessive cytokine production. Whether fractures are also increased in MGUS is unknown.<\/jats:p>\n               <jats:p>Materials and Methods: In a population-based retrospective cohort study, 488 Olmsted County, MN, residents with MGUS first diagnosed in 1960\u20131994 (52% men; mean age, 71.4 \u00b1 12.8 years) were followed for 3901 person-years; follow-up was censored at progression to myeloma. The relative risk of fractures was assessed by standardized incidence ratios (SIRs), and risk factors were evaluated in proportional hazards models.<\/jats:p>\n               <jats:p>Results and Conclusions: Altogether, 200 patients experienced 385 fractures. Compared with expected rates in the community, statistically significant increases were seen for fractures at most axial sites, for example, vertebrae (SIR, 6.3; 95% CI, 5.2\u20137.5). There was a slight increase in hip (SIR, 1.6; 95% CI, 1.2\u20132.2) but not distal forearm fractures (SIR, 0.8; 95% CI, 0.4\u20131.5). The relative risk (SIR) of any axial fracture was 2.7 (95% CI, 2.3\u20133.1) compared with only 1.1 (95% CI, 0.9\u20131.4) for all limb fractures combined. In a multivariate analysis, the independent predictors of any subsequent fracture were age (hazard ratio [HR] per 10-year increase, 1.4; 95% CI, 1.2\u20131.6) and corticosteroid use (HR, 1.8; 95% CI, 1.2\u20132.6); greater weight at diagnosis (HR per 10 kg, 0.8; 95% CI, 0.8\u20130.9), and IgG monoclonal protein (HR, 0.7; 95% CI, 0.5\u20130.97) were protective. Baseline monoclonal protein level, a determinant of myeloma progression, did not predict fracture risk. Thus, the risk of axial, but not peripheral, fractures is increased among MGUS patients even before progression to myeloma. The pathophysiologic basis for this should be determined because elevated bone turnover, for example, might be treatable.<\/jats:p>","DOI":"10.1359\/jbmr.0301212","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T05:58:24Z","timestamp":1146117504000},"page":"25-30","source":"Crossref","is-referenced-by-count":144,"title":["Fracture Risk in Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.1093","volume":"19","author":[{"suffix":"III","given":"L Joseph","family":"Melton","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"},{"name":"Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L","family":"Oberg","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019221105900_bib1","first-page":"4","volume-title":"Cancer Facts & Figures 2003","author":"Anonymous","year":"2003"},{"key":"2024013019221105900_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"2024013019221105900_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(92)90190-M","article-title":"Bone densitometry in patients with multiple myeloma","volume":"93","author":"Mariette","year":"1992","journal-title":"Am J Med"},{"key":"2024013019221105900_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2141.1997.1042920.x","article-title":"Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: Effects of glucocorticoid therapy and disease activity","volume":"97","author":"Diamond","year":"1997","journal-title":"Br J Haematol"},{"key":"2024013019221105900_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199809059252","article-title":"Biologic and therapeutic determinants of bone mineral density in multiple myeloma","volume":"32","author":"Dhodapkar","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"2024013019221105900_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0954-6820.1982.tb01895.x","article-title":"Bone mineral content in myelomatosis","volume":"211","author":"Ingeberg","year":"1982","journal-title":"Acta Med Scand"},{"key":"2024013019221105900_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0609.1996.tb01395.x","article-title":"Assessment of bone involvement in patients with multiple myeloma using bone densitometry","volume":"57","author":"Abildgaard","year":"1996","journal-title":"Eur J Haematol"},{"key":"2024013019221105900_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"Bataille","year":"1991","journal-title":"J Clin Invest"},{"key":"2024013019221105900_bib9","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","article-title":"Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies","volume":"87","author":"Bataille","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"2024013019221105900_bib10","first-page":"23","article-title":"New insights in the clinical biology of multiple myeloma","volume":"34","author":"Bataille","year":"1997","journal-title":"Semin Hematol"},{"issue":"Suppl 17","key":"2024013019221105900_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.34071","article-title":"Advances in the biology and treatment of myeloma bone disease","volume":"29","author":"Berenson","year":"2002","journal-title":"Semin Oncol"},{"key":"2024013019221105900_bib12","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1182\/blood.V90.9.3743","article-title":"Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: Quantification by urinary pyridinium cross-linkage of collagen","volume":"90","author":"Pecherstorfer","year":"1997","journal-title":"Blood"},{"key":"2024013019221105900_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance: Analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"key":"2024013019221105900_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","article-title":"Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance","volume":"31","author":"Diamond","year":"2001","journal-title":"Int Med J"},{"key":"2024013019221105900_bib15","first-page":"140","article-title":"Serum osteocalcin in the management of myeloma","volume":"29A","author":"Williams","year":"1992","journal-title":"Eur J Cancer"},{"key":"2024013019221105900_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02230356","article-title":"Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma","volume":"15","author":"Laroche","year":"1996","journal-title":"Clin Rheumatol"},{"key":"2024013019221105900_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"2024013019221105900_bib18","first-page":"1","article-title":"The incidence and epidemiology of plasma cell neoplasms","volume":"13","author":"Bergsagel","year":"1995","journal-title":"Stem Cells"},{"key":"2024013019221105900_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.7326\/0003-4819-132-9-200005020-00009","article-title":"The role of bisphosphonates in multiple myeloma","volume":"132","author":"Kyle","year":"2000","journal-title":"Ann Intern Med"},{"key":"2024013019221105900_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11864-001-0041-5","article-title":"Bone disease in myeloma","volume":"2","author":"Berenson","year":"2001","journal-title":"Curr Treatment Options Oncol"},{"key":"2024013019221105900_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"2024013019221105900_bib22","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJM199711133372012","article-title":"The threat to medical-records research","volume":"337","author":"Melton","year":"1997","journal-title":"N Engl J Med"},{"key":"2024013019221105900_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024013019221105900_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003086-198103000-00008","article-title":"Epidemiologic features of pelvic fractures","volume":"155","author":"Melton","year":"1981","journal-title":"Clin Orthop"},{"key":"2024013019221105900_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003086-198208000-00003","article-title":"Epidemiologic features of humeral fractures","volume":"168","author":"Rose","year":"1982","journal-title":"Clin Orthop"},{"key":"2024013019221105900_bib26","first-page":"146","article-title":"Downturn in hip fracture incidence","volume":"111","author":"Melton","year":"1996","journal-title":"Public Health Rep"},{"key":"2024013019221105900_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s001980050073","article-title":"Long-term trends in the incidence of distal forearm fractures","volume":"8","author":"Melton","year":"1998","journal-title":"Osteoporos Int"},{"key":"2024013019221105900_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s001980050113","article-title":"Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time","volume":"9","author":"Melton","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013019221105900_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/biomet\/40.3-4.354","article-title":"Some simple approximate tests for Poisson variates","volume":"40","author":"Cox","year":"1953","journal-title":"Biometrika"},{"key":"2024013019221105900_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2024013019221105900_bib31","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"1980"},{"key":"2024013019221105900_bib32","first-page":"187","article-title":"Regression models and life-tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"2024013019221105900_bib33","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"2024013019221105900_bib34","first-page":"108","article-title":"Dual-energy x-ray absorptiometry in patients with multiple myeloma and benign gammopathies","volume":"14","author":"Laroche","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"2024013019221105900_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.2002.17.1.11","article-title":"Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density","volume":"17","author":"Riggs","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019221105900_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/clinchem\/47.4.686","article-title":"Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis","volume":"47","author":"Woitge","year":"2001","journal-title":"Clin Chem"},{"key":"2024013019221105900_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0609.1994.tb01327.x","article-title":"Letter to the editor: Dual energy X-ray absorptiometry measurements of bone mineral density in myeloma","volume":"53","author":"Holmes","year":"1994","journal-title":"Eur J Haematol"},{"key":"2024013019221105900_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.1990.tb07904.x","article-title":"Osteoblast stimulation in multiple myeloma lacking lytic bone lesions","volume":"76","author":"Bataille","year":"1990","journal-title":"Br J Haematol"},{"key":"2024013019221105900_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int"},{"key":"2024013019221105900_bib40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"2024013019221105900_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/B978-012470862-4\/50031-3","volume-title":"Osteoporosis","author":"Cauley","year":"2001","edition":"2nd ed."},{"key":"2024013019221105900_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019221105900_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s001980070062","article-title":"Drug-induced bone loss","volume":"11","author":"Tannirandorn","year":"2000","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.0301212","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/1\/25\/56474110\/5650190105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/19\/1\/25\/56474110\/5650190105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:06:00Z","timestamp":1710342360000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/19\/1\/25-30\/7592740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.0301212","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,1,1]]},"published":{"date-parts":[[2004,1,1]]}}}